TY - JOUR
T1 - Therapeutic maps for a sensor-based evaluation of deep brain stimulation programming
AU - Bremm, Rene Peter
AU - Berthold, Christophe
AU - Krüger, Rejko
AU - Koch, Klaus Peter
AU - Goncąlves, Jorge
AU - Hertel, Frank
N1 - Funding Information:
Research funding: This work was supported by the Fonds National de la Recherche Luxembourg with an PhD Grant (10086156, Rene Peter Bremm). The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Publisher Copyright:
© 2021 Walter de Gruyter GmbH, Berlin/Boston 2021
PY - 2021/11/2
Y1 - 2021/11/2
N2 - Programming in deep brain stimulation (DBS) is a labour-intensive process for treating advanced motor symptoms. Specifically for patients with medication-refractory tremor in multiple sclerosis (MS). Wearable sensors are able to detect some manifestations of pathological signs, such as intention tremor in MS. However, methods are needed to visualise the response of tremor to DBS parameter changes in a clinical setting while patients perform the motor task finger-to-nose. To this end, we attended DBS programming sessions of a MS patient and intention tremor was effectively quantified by acceleration amplitude and frequency. A new method is introduced which results in the generation of therapeutic maps for a systematic review of the programming procedure in DBS. The maps visualise the combination of tremor acceleration power, clinical rating scores, total electrical energy delivered to the brain and possible side effects. Therapeutic maps have not yet been employed and could lead to a certain degree of standardisation for more objective decisions about DBS settings. The maps provide a base for future research on visualisation tools to assist physicians who frequently encounter patients for DBS therapy.
AB - Programming in deep brain stimulation (DBS) is a labour-intensive process for treating advanced motor symptoms. Specifically for patients with medication-refractory tremor in multiple sclerosis (MS). Wearable sensors are able to detect some manifestations of pathological signs, such as intention tremor in MS. However, methods are needed to visualise the response of tremor to DBS parameter changes in a clinical setting while patients perform the motor task finger-to-nose. To this end, we attended DBS programming sessions of a MS patient and intention tremor was effectively quantified by acceleration amplitude and frequency. A new method is introduced which results in the generation of therapeutic maps for a systematic review of the programming procedure in DBS. The maps visualise the combination of tremor acceleration power, clinical rating scores, total electrical energy delivered to the brain and possible side effects. Therapeutic maps have not yet been employed and could lead to a certain degree of standardisation for more objective decisions about DBS settings. The maps provide a base for future research on visualisation tools to assist physicians who frequently encounter patients for DBS therapy.
KW - accelerometers
KW - deep brain stimulation
KW - multiple sclerosis
KW - short-time Fourier transform
KW - tremor
UR - http://www.scopus.com/inward/record.url?scp=85119061786&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/34727584
U2 - 10.1515/bmt-2020-0210
DO - 10.1515/bmt-2020-0210
M3 - Article
AN - SCOPUS:85119061786
SN - 0013-5585
VL - 66
SP - 603
EP - 611
JO - Biomedizinische Technik
JF - Biomedizinische Technik
IS - 6
ER -